In the news:
Tech layoffs update: AMD, iRobot, 23andMe, and other big firms see job losses in November 2024 - Victims of 23andMe's Data Breach Could Get $10,000. Here's What You Need to Know - 23andMe is ending its cancer research program and slashing over 200 jobs - 23andMe reports sales decline a day after announcing plans to cut 40% of workforce - 23andMe Lays Off 40% of Staff, Shuts Drug Development Business - 23andMe to lay off 40% of its workforce as stock price plummets - What happens to customer data as 23andMe goes out of business? - 23andMe cuts 40% of staff in restructuring - 23andMe is laying off 40 percent of its staff - 23andMe is laying off 40% of its workforce right before the holiday season
23andMe
Save
ShareKey facts
- city: South San Francisco
- state: CA
- country: United States
- sector: Health Care
- foundation year: 2006
- industry: Health Care Providers & Services
- CEO: Anne Wojcicki
Classified as: organization
Summary
23andMe is a company. It is located in South San Francisco, the United States and was founded in 2006. The company is part of the Health Care sector, specifically in the Health Care Providers & Services industry.
Business see more
23andMe is one of the companies in the United States, companies in Health Care Providers & Services, companies in Health Care and 3,466,499 companies in our database.
- Assets: 1.2B $
- Debt: 86.3M $
- Employees:
get
Premium to see estimate
- Free cash flow: -64259600 $
- Market cap: 1.6B $
- Profits: -217490000 $
- Revenues: 271.9M $
Stocks from 23andMe
Talking Points:
- DNA Genetic Testing For Health, Ancestry And More - 23andMe United Kingdom
- 23andMe offers DNA testing with the most comprehensive ancestry breakdown, personalized health insights and more.
- Your DNA has a lot to say about your health, traits and ancestry. For help, tweet us @23andMesupport.
- Our mission is to help people access, understand and benefit from the human genome. | 23andMe, headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company's mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as ...
- 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No.3) Limited to leverage genetic insights to validate, develop, and commercialize drugs. The company was founded in 2006 and is headquartered in South San Francisco, California.
Learn more about talking points